Product Details:
Manufacturer | Intas |
Prescription/Non prescription | Prescription |
Packaging Size | 1*10 Capsules |
Strength | 1.0 mg |
Pack size | 1 x 10 Capsules |
Brand | Takfa 1 |
Composition | Tacrolimus 1 mg |
Treatment | For Kidney,Liver,and Heart Transplant Recovery |
Packaging Type | Box |
Introduction: Takfa 1 mg is a medication that contains the active ingredient Tacrolimus, which belongs to the class of immunosuppressants. This pharmaceutical product is available in capsule form and is primarily prescribed to prevent organ rejection in patients who have undergone solid organ transplantation, such as kidney, liver, or heart transplant recipients. By modulating the immune response, Takfa helps ensure the transplanted organ is not attacked and rejected by the body's immune system.
Active Ingredient - Tacrolimus: Tacrolimus is the key component of Takfa 1 mg and is a potent immunosuppressive agent. It works by inhibiting the activation of T-lymphocytes (T-cells), a type of white blood cell crucial for the immune system's normal functioning. By blocking T-cell activation, Tacrolimus reduces the immune system's response, preventing it from recognizing and attacking the transplanted organ as a foreign body.
Dosage and Administration: Takfa 1 mg capsules are meant for oral administration and are available in the prescribed dosage strength of 1 mg. The exact dosage may vary depending on various factors, such as the type of organ transplanted, the patient's weight, medical history, and response to treatment. It is essential for patients to strictly adhere to the prescribed dosage and follow the administration instructions provided by their transplant specialist or healthcare professional. Any adjustments to the dosage should only be made under medical supervision.
Precautions: Patients taking Takfa 1 mg should be aware of certain precautions to ensure safe and effective treatment. Avoiding exposure to strong sunlight or ultraviolet (UV) light is crucial, as Tacrolimus can increase skin sensitivity and cause sunburn or other skin reactions. Wearing protective clothing and using sunscreen when outdoors can help minimize these risks.
Side Effects: As with any medication, Takfa 1 mg may cause some side effects. Common side effects may include headache, upset stomach, diarrhea, and mild tremors. These side effects are usually transient and not a cause for concern. However, if any side effects persist or become bothersome, patients should promptly inform their healthcare provider.
In some cases, Takfa may lead to more serious side effects, such as high blood pressure, kidney problems, neurological issues, or an increased risk of infections. It is crucial to seek medical attention immediately if any unusual or severe symptoms occur during the course of treatment.
Additional Information:
Product Details:
Pack Size | 1*30 Tablet |
Pack Type | Strips |
Manufacturer | Zydus Oncosciences |
Composition | Erlotinib |
Brand | Zyceva 100 |
Packaging size | 30 Tablets Per Pack |
Form | Tablet |
Treatment | For Lung Cancer Treatment |
Storage | Keep It At Cool And Dry Place |
Dose Strenght | 100 mg |
Description:
Erlotinib 100 mg IP Tablet is a targeted cancer medication that belongs to the class of drugs known as tyrosine kinase inhibitors. It is specifically designed to inhibit the activity of certain proteins, particularly the epidermal growth factor receptor (EGFR), which are responsible for promoting the growth and division of cancer cells. This tablet is a vital component in the treatment of certain types of advanced or metastatic cancers.
Indications:
Erlotinib 100 mg IP Tablet is primarily indicated for the treatment of metastatic non-small cell lung cancer (NSCLC) that has specific genetic mutations in the EGFR gene. It is used as a first-line treatment in patients with these EGFR mutations. Additionally, it may be prescribed for other cancer types that overexpress the EGFR protein.
Mode of Action:
The active ingredient, Erlotinib, works by selectively targeting and inhibiting the activity of the EGFR protein. EGFR is involved in signaling pathways that promote cell growth and division. In cancers with EGFR mutations or overexpression, this signaling becomes dysregulated, leading to uncontrolled cancer cell growth. By inhibiting EGFR, Erlotinib helps to slow down cancer cell growth, reduce tumor size, and impede the spread of cancer.
Dosage and Administration:
The dosage of Erlotinib 100 mg IP Tablet is prescribed by an oncologist and may vary based on the patient's individual medical condition and response to treatment. It is usually taken orally once daily on an empty stomach, at least one hour before or two hours after eating. Swallow the tablet whole with a glass of water, and avoid crushing or chewing it.
Precautions:
Product Details:
Minimum Order Quantity | 6 Stripe |
Manufactured By | Concord |
Manufacturer | CONCORD |
Drug Name | Evercon |
Generic Name | Everolimus |
Prescription/Non prescription | Prescription |
Composition | Everolimus |
Brand | Evercon 0.5 mg |
Packaging Size | Strip of 10 Tablets |
Treatment | Anti Cancer Liver Transplant |
Country of Origin | Made in India |
Product Details:
Packaging Size | 6 x 10 Tablets |
Dose/Strength | 360 mg |
Usage/Application | Hospital |
Dosage Form | Tablets |
Manufactured By | Panacea Biotec |
Packaging Type | Box |
Medicine Type | Allopathic |
Brand | Mycept-S |
Storage | Store In a Dry Place at a Temperature not More Then 30 Degree C |
Composition | Mychophenolic Acid Delayed Release USP 360 mg |
Treatment | For Kidney Transplant Recovery |
Product Details:
Packaging Type | Box |
Brand | Mycophen 500 |
Composition | Mycophenolote Mofetil |
Packaging Size | 6 x 10 Tablets |
Dose | 500 mg |
Manufacturer | Micro |
Product Details:
Packaging size | 6 x 10 Tablets |
Form | Tablet |
Composition | Mycophenalate Sodium |
Manufacturer | Steadfast Medishield |
Prescription/Non prescription | Prescription |
Treatment | Kidney Transplant |
Strength | 360 mg |
Brand | My 360 |
Usage | Used with other medicines to lower the body's natural immunity in patients who receive kidney transplants |
Product Details:
Packaging Type | Box |
Generic Name | Mycophenalate mofetil |
Brand | Mofilet 500 |
Form | Tablet |
Composition | Mycophenolate Mofetil USP IP 500 mg |
Pack Size | 6 Blister Strip Of 10 Tablets Each |
Treatment | For Kidney,Heart,Or Liver Transplant Treatment |
Manufacturer | Emcure |
Product Details:
Minimum Order Quantity | 5 Strip |
Manufacturer | Intas |
Prescription/Non prescription | Prescription |
Packaging Type | Strips |
Medicine Type | Allopathic |
Packaging Size | 1 x 10 Tablets |
Brand | PTH 30 |
Usage/Application | Anti-Infective |
Dose | 30 mg |
Product Details:
Packaging Size | 28 tablets |
Strength | 400 mg |
Composition | Sofosbuvir |
Treatment | For Liver Cancer and Hepatitis C Infection |
Brand | Novisof |
Manufacturer | Wockhardt |
Form | Tablet |
Dosage Form | Tablet |
Product Details:
Manufacturer | Steadfast Medishield |
Form Of Medicines | Tablets |
Packaging Type | Box |
Medicine Type | Allopathic |
Brand | My360 |
Treatment | For Kidney,Heart,Or Liver Transplant Recovery |
Tablet In Pack | 5 x 10 Tablets |
Composition | Enteric Coated Mycophenolate Sodium 360 mg |
Product Details:
Dose/Strength | 200 mg |
Composition | Ledipasvir and Sofosbuvir |
Brand | Hepcvir L |
Packaging Size | 20 Tablets |
Usage/Application | Hepatitis C virus protection |
Manufactured By | Cipla |
Packaging Type | Box |
Product Details:
Packaging Size | 45 Tablets |
Composition | Sariglitazar |
Packaging Type | Box |
Brand | Bilypsa |
Form | Tablet |
Manufacturer | Zydus BioNext |
Dose | 4 mg |
Product Details:
Strength | 400 mg |
Pack size | 28 Tablets |
Packaging Type | Box |
Composition | Sofosbuvir IP 400 mg |
Treatment | For Liver Cancer and Hepatitis C Infection |
Form | Tablet |
Brand | Hepcinat |
Manufacturer | Natco |
Instructions | Keep It At Cool And Dry Place |
We have carved a niche amongst the most dominant names in this domain, involved in providing a superior quality range of Hepcinat Sofosbuvir 400 mg Tablet.
Product Details:
Minimum Order Quantity | 10 Pack |
Packaging Type | Box |
Composition | Alpha Ketoanalogue |
Packaging Size | 10 x 10 Tablets |
Manufacture By | Steadfast Medishield |
Brand | Aplazar |
Usage/Application | For Kidney Disease |
Dosage Form | Tablet |
Dosage | As Directed By Physician |
We have gained a remarkable position in the market that is involved in offering Aplazar Alpha Ketoanalogue Tablet.
Product Details:
Minimum Order Quantity | 10 Box |
Form | Tablet |
Composition | Gefitinib IP 250 mg |
Packaging size | 30 Tablets |
Treatment | For Lung Cancer Treatment |
Manufacturer | Natco |
Brand | Geftinat |
Strength | 250 mg |
Additional Information:
Product Details:
Minimum Order Quantity | 10 Strip |
Strength | 400 mg |
Dose/Strength | 400 mg |
Manufacturer | Emcure |
Brand | Sevcar-400 |
Pack size | 5 Blister Strips of 10 Tablets Each |
Form | Tablet |
Composition | Sevelamer Carbonate |
Packaging Type | Box |
Prescription/Non prescription | Prescription |
Treatment | For Kidney Disease |
Storage | Store Below 30 Degree C,In a Dry Place Protected From Light |
As per the needs and requirements of our clients, we are involved in providing Sevelamer Carbonate 400 mg Tablet.
Additional Information:
Product Details:
Packaging Type | Box |
Usage/Application | Chronical Kidney Disease |
Packaging Size | 100 Film Coated Tablets |
Brand | Ketosteril |
Shelf Life | 18 Months |
Prescription/Non Prescription | Prescription |
Dosage Form | Tablet |
Manufacturer | Fresenius Kabi |
Country of Origin | Made in India |
Product Details:
Packaging Type | Box |
Packaging Size | 5 x 15 Tablets |
Prescription/Non-Prescription | Prescription |
Manufacturer | Steadfast Medishield |
Composition | Sodium Bicarbonate |
Brand | Nodosis DS |
Usage | Used to Relieve Heartburn,Sour Stomach,or Acid Indigestion by Neutralizing Excess Stomach Acid |
Product Details:
Strength | 200 mg |
Composition | Pazopanib Hydrochloride |
Packaging size | 30 Tablets Per Pack |
Form | Tablet |
Treatment | For Kidney Cancer Treatment |
Type | Film Coated Tablets |
Dose Strength | 200 mg |
Brand | Votrient |
Manufacturer | GlaxoSmithKline |
Description:
Votrient Pazopanib 200 mg Tablet is a targeted cancer medication that belongs to the class of drugs known as tyrosine kinase inhibitors. It is specifically designed to inhibit the growth and spread of cancer cells by targeting certain proteins that promote tumor growth and blood vessel formation. This tablet is an essential component in the treatment of certain advanced or metastatic cancers.
Indications:
Votrient Pazopanib 200 mg Tablet is primarily indicated for the treatment of advanced renal cell carcinoma (RCC), a type of kidney cancer. It is also used to treat advanced soft tissue sarcoma (STS), a type of cancer that affects the connective tissues of the body, in patients who have previously received chemotherapy.
Mode of Action:
Pazopanib, the active ingredient in Votrient, works by inhibiting several receptor tyrosine kinases, including those associated with vascular endothelial growth factor (VEGF) receptors, platelet-derived growth factor (PDGF) receptors, and fibroblast growth factor (FGF) receptors. These receptors play critical roles in tumor growth, angiogenesis (blood vessel formation), and metastasis (spread of cancer). By blocking these receptors, Votrient slows down the growth of tumors and reduces their blood supply, thus impeding their progression.
Dosage and Administration:
The dosage of Votrient Pazopanib 200 mg Tablet is prescribed by an oncologist and may vary based on the patient's individual medical condition and response to treatment. It is usually taken orally once daily with or without food, as directed by the healthcare provider. Swallow the tablet whole with a glass of water, and avoid crushing or chewing it.
Precautions:
Product Details:
Minimum Order Quantity | 1 Strip |
Dose/Strength | 600 mg |
Form | Tablet |
Brand | Oxitres |
Number Of Tablets | 5 x 10 Tablets |
Main Composition | N-Acetylcysteine |
Usage/Application | Pain Relief |
Manufacturer | Steadfast Medishield |
Packaging type | Box |